The arrival of COVID-19 in Japan in early 2020 prompted a concerted research effort at RIKEN. A strong research capacity in immunology, molecular biology.
Idris Elba feels âincredibly luckyâ to have fully recovered from COVID-19.
The 48-year-old actor tested positive for coronavirus back in March last year, but didnât suffer any serious symptoms and made a full recovery without any âresidual side effectsâ.
And the âConcrete Cowboysâ star has now said he knows how lucky he is to have had an easy time with the virus, which has claimed the lives of almost three million people worldwide.
He told USA Today: âI donât suffer any residual effects and during my time with COVID, I was asymptomatic. But I guess I feel incredibly lucky to have not gone down the worst route and thus itâs given me a slightly different perspective on life, a little bit more of a new lease on life. There are things that Iâve always wanted to do and havenât done that Iâm doing and want to do and pursuing. Personal things, small goals, things that I just put aside, things that I just said, âOh, Iâ
E-Mail
IMAGE: Researchers from The University of Tokyo develop a novel device for the safe and effective transplantation of human induced pluripotent stem cell (iPSC)-derived pancreatic beta-cells in type I diabetes mellitus. view more
Credit: Institute of Industrial Science, the University of Tokyo
Tokyo, Japan - Type I Diabetes Mellitus (T1D) is an autoimmune disorder leading to permanent loss of insulin-producing beta-cells in the pancreas. In a new study, researchers from The University of Tokyo developed a novel device for the long-term transplantation of iPSC-derived human pancreatic beta-cells.
T1D develops when autoimmune antibodies destroy pancreatic beta-cells that are responsible for the production of insulin. Insulin regulates blood glucose levels, and in the absence of it high levels of blood glucose slowly damage the kidneys, eyes and peripheral nerves. Because the body loses the ability to produce insulin over time, the current mainstay of treatment fo
PIKEVILLE â A year after Pike Countyâs first confirmed case of COVID-19, local health officials are continuing to learn more about the long-term effects of the virus.
Although most people recover completely from COVID-19 within a few weeks, some patients, known as âCOVID-19 long-haulers,â have developed persistent COVID-19 symptoms or long-term health effects from the virus for up to at least six months after their initial recovery.
Dr. Fadi Al Akhrass, Medical Director of Infectious Diseases and Infection Control with Pikeville Medical Center, said that Pikeville Medical Center has seen many patients who are currently experiencing or who have experienced persistent COVID-19 symptoms after their initial recovery. In addition, he said, he has studied research data from studies on the long-term effects from COVID-19 from the past year in order to see what national medical experts have found in their patients.
DR. KEITH ROACH
For the Herald & Review
DEAR DR. ROACH: My daughter-in-law has anxiety attacks. It gets so bad that she ends up throwing up. She has seen a doctor, but so far it has not helped. Can you give her any advice? M.L.
A: Anxiety is something that nearly everyone has felt when confronted by a difficult, unexpected or time-consuming problem. An anxiety disorder is different.
Generalized anxiety disorder is excessive and persistent worrying that is hard to control, causes significant distress or impairment, and occurs on more days than not for at least six months. Some physical symptoms are hallmarks: Poor sleep, fatigue, headaches and pain in the neck, shoulders and back are among the most common, but vomiting is possible in people with more-severe cases of anxiety. Panic attacks often co-exist with severe anxiety disorders.